CENTRIS LIMITED
Company number 02992279 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Score: B
Explanation: The company is solvent, liquid, and fully compliant with its filing obligations, with no long-term debt and positive working capital. However, net assets have declined for two consecutive years, and the absence of a filed profit and loss account means profitability cannot be confirmed from the public record. This combination supports a “sound but watchful” grade rather than a higher one.
Key Vital Signs
| Metric | Latest (2025) | Prior (2024) | Interpretation |
|---|---|---|---|
| Net Assets / Shareholders’ Funds | £78,147 | £81,563 | Positive equity: the business owns more than it owes. The capital base has contracted by roughly 4.2% in the last year and about 19.7% since its 2023 peak. |
| Net Current Assets (Working Capital) | £69,612 | £72,443 | Short-term assets exceed short-term debts by a comfortable margin. |
| Current Ratio (approx.) | 1.9 : 1 | 1.85 : 1 | Current assets of £146,608 against creditors due within one year of £76,996. The company can cover its near-term obligations nearly twice over—a healthy liquidity pulse. |
| Total Assets | £155,143 | £166,828 | The asset base has shriven by about 7.0% year-on-year. |
| Long-Term Debt | None reported | None reported | No creditors falling due after more than one year; the balance sheet is equity-funded with no gearing risk. |
| Filing Compliance | Up to date | Up to date | Accounts and confirmation statement are not overdue; no administrative distress signals. |
| Director Advances | £5,073 total (the accounts state advances of £4,630 and £443, unsecured and repayable on demand) | £631 total | Small owner withdrawals that are repayable on demand. Low immediate risk, but worth monitoring if they grow. |
| Employees | 3 | 2 | Stable, very small team. |
Diagnosis
The company’s condition is best described as stable but showing early signs of capital erosion. There are no symptoms of acute insolvency: net assets are strongly positive, working capital is healthy, creditors are modest, and there is no long-term debt. Filings are current, and the company remains active.
The principal symptom is a gradual decline in shareholders’ funds: net assets fell from £97,337 in 2023 to £81,563 in 2024 and £78,147 in 2025. Total assets and current assets have also contracted over the same period. Because micro-entity accounts filed at Companies House do not include a detailed profit and loss account, it is not possible from the public record to determine whether this decline is driven by trading losses, owner drawings, or a combination of both.
The accounts state that director advances increased during the year (to £4,630 and £443, unsecured and repayable on demand). These are small relative to the balance sheet and repayable on demand, but a rising trend in owner withdrawals can contribute to equity erosion if not offset by profits.
Prognosis
Short-term: Favorable. The company has sufficient liquidity to meet its obligations as they fall due and faces no immediate solvency threat.
Medium-term: Guarded. If net assets continue to decline at the recent rate, the equity cushion will thin over time. The outlook depends on whether the underlying business is profitable and whether owner withdrawals are sustainable. Without profitability data, the prognosis cannot be confirmed as positive.
Recommendations
- Obtain the internal profit and loss account. The filed micro-entity balance sheet does not reveal turnover, gross profit, or operating profit. Review internal management accounts to establish whether the company is trading at a profit or loss.
- Investigate the decline in net assets. Determine whether the reduction in shareholders’ funds is due to retained losses, dividends, or director drawings, and address the root cause.
- Monitor director loan accounts. Ensure the advances stated in the accounts are repaid on demand as agreed, and consider setting clear limits or formal terms for any future withdrawals.
- Protect working capital. The £11,000 reduction in current assets should be examined—review cash holdings, debtor collection, and inventory levels to prevent further liquidity creep.
- Prepare a cash flow forecast. A rolling 12-month forecast will confirm that the healthy current ratio can be maintained and will flag any future shortfalls early.
- Maintain filing discipline. Continue submitting accounts and confirmation statements on time to avoid penalties and preserve the company’s clean regulatory record.